Immune mechanisms in pulmonary fibrosis.
Am. J. Respir. Cell Mol. Biol. 55, 309-322 (2016)
Pulmonary fibrosis, particularly idiopathic pulmonary fibrosis, represents a chronic and progressive disease with high mortality and limited therapeutic options. Excessive deposition of extracellular matrix proteins results in fibrotic remodeling, alveolar destruction and irreversible loss of lung function. Both innate and adaptive immune mechanisms contribute to fibrogenesis at several cellular and non-cellular levels. Here, we summarize and discuss the role of immune cells (T cells, neutrophils, macrophages and fibrocytes) and soluble mediators (cytokines and chemokines) involved in pulmonary fibrosis, pointing towards novel immune-based therapeutic strategies in the field.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Review
Thesis type
Editors
Keywords
T Cells ; Fibrosis ; Immunity ; Lung ; Neutrophils; Epithelial-mesenchymal Transition; Growth-factor-beta; Muc5b Promoter Polymorphism; Human Lung Fibroblasts; Regulatory T-cells; Gamma-delta T; Bronchoalveolar Lavage Fluid; Tyrosine Kinase Inhibitor; Versus-host-disease; Tgf-beta
Keywords plus
Language
english
Publication Year
2016
Prepublished in Year
HGF-reported in Year
2016
ISSN (print) / ISBN
1044-1549
e-ISSN
1535-4989
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 55,
Issue: 3,
Pages: 309-322
Article Number: ,
Supplement: ,
Series
Publisher
American Thoracic Society
Publishing Place
New York
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Lung Research
PSP Element(s)
G-501600-001
G-505000-006
Grants
Copyright
Erfassungsdatum
2016-05-09